BATS BZX Real-Time Price
As of 3:38pm ET
| -0.01 / -0.10%|
The 2 analysts offering 12-month price forecasts for ZIOPHARM Oncology Inc have a median target of 15.50, with a high estimate of 21.00 and a low estimate of 10.00. The median estimate represents a +48.33% increase from the last price of 10.45.
The current consensus among 4 polled investment analysts is to Hold stock in ZIOPHARM Oncology Inc. This rating has held steady since September, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.